Lose 19% of your body weight on average in 1 year* FDA-approved GLP-1 for weight loss, now available in a new higher dose (HD) for patients with obesity Use insurance or pay cash What is Wegovy
According to FDA-approved prescribing information, gastrointestinal adverse effects occur commonly with these medications, with nausea reported in 16-44% of patients, vomiting in 6-24%, and abdominal pain or distension in 5-18%, depending on the specific medication and dosage
If you are within four days (96 hours) of your missed dose, take it as soon as you remember
Boston, MA Frequently asked questions In the SURMOUNT-1 trial published in The New England Journal of Medicine (Jastreboff et al., 2022), participants on weekly tirzepatide 15 mg lost an average of 20.9% of body weight at 72 weeks versus 3.1% on placebo
Because of this difference, safety largely depends on the pharmacy preparing the medication and the controls in place
There are zero hidden fees, no mandatory membership subscriptions, and no surprise medical costs
